Dr. Karamallah Shaker Al Yousef, a teacher at the Faculty of Pharmacy, received his Ph.D. in Clinical pharmacology from the University of Dundee/ UK, after completing the discussion of his tagged thesis Study of the pharmacological efficacy of melanoma with the use of the drug of the bachelor. And MEK Inhibitor. Where Dr. Karamallah explained: The purpose of the research is to develop A new treatment for malignant melanoma skin cancer, which is considered one of the most severe Cancers are human-killing, and laboratory results obtained in terms of
Manufacturing, purifying and testing treatment on living tissues and laboratory animals provide supplant Good for testing on skin cancer patients in global conditions and contexts
